COMMUNIQUÉS West-GlobeNewswire

Avadim Technologies Announces Name Change To Avadim Health, Inc.

17/09/2018 - 15:00

Name Change To Reflect Company Vision – “To Take Healing To The Nations” ASHEVILLE, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Avadim Technologies Inc. (“Avadim”), the Bionome Therapies TM life sciences company, announced [...]

Transactions under Novozymes’ stock buyback program

17/09/2018 - 14:57

Please read the full announcement in the attached PDF Attachment 2018_54_Stock_Buybackprogram_EN

PSI’s Acquisition of KINEX Strengthens Company’s Position as an IT Leader

17/09/2018 - 14:56

ARLINGTON, Va., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI) is pleased to announce that it has acquired KINEX, Inc., a company in business for over 20 years providing mission-critical [...]

GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions

17/09/2018 - 14:43

Villepinte (France), le 17 septembre 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 [...]

Extendicare Announces September 2018 Dividend of C$0.04 per Share

17/09/2018 - 14:35

MARKHAM, Ontario, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]

New Independent Data Further Demonstrates Clinical Utility of Daxor Corporation’s Blood Volume Analyzer (BVA-100) Over Surrogate Measurements

17/09/2018 - 14:30

NEW YORK, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]

Ultragenyx Expands Leadership Team and Appoints Dr. Wladimir Hogenhuis as Chief Operating Officer

17/09/2018 - 14:30

NOVATO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Osteosarcoma

17/09/2018 - 14:30

MADISON, Wis., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]

Menlo Therapeutics Begins European Prurigo Nodularis Phase 3 Trial and Presents Additional Data from PN Phase 2 Trial at EADV

17/09/2018 - 14:30

~Additional Exploratory Analyses of Phase 2 Clinical Trial of Serlopitant in Prurigo Nodularis Presented at the European Academy of Dermatology and Venereology Congress~ REDWOOD CITY, Calif., Sept. 17, 2018 (GLOBE [...]

Novo Nordisk A/S - Share repurchase programme

17/09/2018 - 14:29

Bagsværd, Denmark, 17 September 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants

17/09/2018 - 14:26

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Sept. 17, 2018 (GLOBE NEWSWIRE) -- [...]

Tabula Rasa HealthCare’s Newly Acquired Subsidiary, Mediture, Expands Managed Long-term Care Services with Visiting Nurse Service of New York

17/09/2018 - 14:21

MOORESTOWN, N.J., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC) , a healthcare technology company advancing the field of medication safety, today announced its subsidiary, [...]

Apotheca Biosciences (PCFP) Overviews Pain-Patch, an Opioid Substitution

17/09/2018 - 14:02

Saint Petersburg, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]

VBL Therapeutics to Present at Upcoming Conferences in October

17/09/2018 - 14:00

TEL AVIV, Israel, Sept. 17, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Eidos Therapeutics Presents Data from its Phase 1 Clinical Trial of AG10 at the 22nd Annual Scientific Meeting of the Heart Failure Society of America

17/09/2018 - 14:00

SAN FRANCISCO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics , Inc. (Eidos) (Nasdaq:EIDX) announced the presentation of results from its Phase 1 clinical trial of AG10 during a poster session at the 22 nd Annual [...]

Spring Bank Pharmaceuticals, Inc. to Present at the 2018 Cantor Global Healthcare Conference

17/09/2018 - 14:00

HOPKINTON, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

Retrotope Announces the Initiation of Expanded Access (Compassionate Use) Trial of RT001 in Amyotrophic Lateral Sclerosis (ALS)

17/09/2018 - 14:00

First ALS patient dosed with RT001 LOS ALTOS, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Retrotope today announced that it has supplied its drug RT001 for the initiation of an expanded access (EA) trial to treat [...]

Coherus BioSciences Management to Present at the 2018 Cantor Global Healthcare Conference in October

17/09/2018 - 14:00

REDWOOD CITY, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will be presenting at the 2018 Cantor Global Healthcare Conference being held in [...]

Conformis Announces Settlement of Patent Dispute with Smith & Nephew

17/09/2018 - 14:00

Conformis to Receive $10.5 Million for Non-Exclusive License to Patient-Specific Instrument Patents for use with off-the-shelf knee implants BILLERICA, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: [...]